WORCESTER, Mass., Oct. 1, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corp. (Nasdaq:GNBT) announced that The NASDAQ Stock Market (Nasdaq:NDAQ) today cancelled trades in security GNBT at or below $0.36 that were executed in NASDAQ between 11:56:00 and 11:58:00 ET. The cancellations were pursuant to NASDAQ Rule 11890 (b) and cannot be appealed. NASDAQ coordinated this decision with other Unlisted Trading Privileges (UTP) Exchanges.
